← Back to Search

Behavioural Intervention

Augmented-Reality Visual Cues for Parkinson's Disease (ELIMINATE-FOG Trial)

N/A

Waitlist Available

Led By James Liao, MD PhD

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for each arm, during the single-day research visit only.

Awards & highlights

ELIMINATE-FOG Trial Summary

This trial will test how effective augmented-reality (AR) glasses are at helping people with Parkinson's Disease reduce their gait freezing (FOG) by providing digital cues that only the wearer can see.

Eligible Conditions

Parkinson's Disease
Movement Disorders
Gait Instability
Festinating Gait
Neurologic Gait Disorders

ELIMINATE-FOG Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for each arm, during the single-day research visit only.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for each arm, during the single-day research visit only.

This trial's timeline: 3 weeks for screening, Varies for treatment, and for each arm, during the single-day research visit only. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent Time Freezing

Stride Time Coefficient of Variation

Secondary outcome measures

Freezing Index

Gait

Mean Stride Length

+3 more

ELIMINATE-FOG Trial Design

1Treatment groups

Experimental Treatment

Group I: Augmented-Reality Visual CuesExperimental Treatment6 Interventions

In this single-arm study, all participants will receive all interventions on the same day. They will be wearing an augmented-reality headset that will display a digital obstacle course. Walking performance will be captured with no visual cues, with conventional visual cues, and with augmented-reality visual cues.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

American Parkinson's Disease Association, IncOTHER

2 Previous Clinical Trials

47 Total Patients Enrolled

The Cleveland ClinicLead Sponsor

1,026 Previous Clinical Trials

1,366,040 Total Patients Enrolled

James Liao, MD PhDPrincipal InvestigatorThe Cleveland Clinic

1 Previous Clinical Trials

12 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the chief ambitions of this clinical experiment?

"This clinical trial aims to measure Percent Time Freezing over the course of a single-day research visit. Secondary outcomes include Step Cadence, an index derived from body-worn wireless sensors that serves as an indicator of dysfunction; Freezing Index, another marker determined by kinematic recordings taken with these sensors; and Gait Velocity which is also indicative of gait disorder due to its correlation with sensor readings."

Answered by AI

Is enrollment available for this clinical trial at present?

"The details available on clinicaltrials.gov suggest that this medical trial is not presently seeking participants, as the last update was posted on November 4th 2022. Nonetheless, there are 1539 other trials actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait

2022. "External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05608915.